| Trial registration number
|
NCT05441631 |
Full text link
Last imported at : July 2, 2022, 11:30 p.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT05441631
|
First author
Last imported at : July 2, 2022, 11:30 p.m.
Source : ClinicalTrials.gov
|
Amr M. El Hammady
|
Contact
Last imported at : July 2, 2022, 11:30 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : July 2, 2022, 11:30 p.m.
Source : ClinicalTrials.gov
|
2022-07-01
|
Recruitment status
Last imported at : July 2, 2022, 11:30 p.m.
Source : ClinicalTrials.gov
|
Completed
|
Study design
Last imported at : July 2, 2022, 11:30 p.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : July 2, 2022, 11:30 p.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : July 2, 2022, 11:30 p.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : July 2, 2022, 11:30 p.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : July 2, 2022, 11:30 p.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : July 2, 2022, 11:30 p.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
diabetic non-diabetic confirmed covid-19 disease both by pcr diagnosis of viral rna and by ct diagnosis of covid-associated pneumonia.
|
Exclusion criteria
Last imported at : July 2, 2022, 11:30 p.m.
Source : ClinicalTrials.gov
|
patients younger than 18 years, patients admitted with critical illness requiring immediate admission to icu, patients deceased before evaluation, patients who had autoimmune diseases or were maintained on immunosuppressive therapy, patients with chronic medical diseases other than dm, patients requiring surgical interference for emergency conditions, and patients who had cancer or were maintained anticancer therapy were excluded from the study.
|
Number of arms
Last imported at : July 2, 2022, 11:30 p.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : July 2, 2022, 11:30 p.m.
Source : ClinicalTrials.gov
|
Benha University
|
Inclusion age min
Last imported at : July 2, 2022, 11:30 p.m.
Source : ClinicalTrials.gov
|
20
|
Inclusion age max
Last imported at : July 2, 2022, 11:30 p.m.
Source : ClinicalTrials.gov
|
65
|
Countries
Last imported at : July 2, 2022, 11:30 p.m.
Source : ClinicalTrials.gov
|
Egypt
|
Type of patients
Last imported at : July 2, 2022, 11:30 p.m.
Source : ClinicalTrials.gov
|
Moderate/severe disease at enrollment
|
Severity scale
Last imported at : July 2, 2022, 11:30 p.m.
Source : ClinicalTrials.gov
|
4: Moderate/severe disease at enrollment
|
Total sample size
Last imported at : July 2, 2022, 11:30 p.m.
Source : ClinicalTrials.gov
|
436
|
primary outcome
Last imported at : July 2, 2022, 11:30 p.m.
Source : ClinicalTrials.gov
|
The relation between application intensive insulin therapy and patients' survival
|
Notes
Last imported at : July 2, 2022, 11:30 p.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : July 2, 2022, 11:30 p.m.
Source : ClinicalTrials.gov
|
Phase 1
|
Arms
Last imported at : July 2, 2022, 11:30 p.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": " Intensive insulin therapy", "treatment_id": 659, "treatment_name": "Insulin", "treatment_type": "Hormones", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "Conventional Subcutaneous insulin therapy", "treatment_id": 659, "treatment_name": "Insulin", "treatment_type": "Hormones", "pharmacological_treatment": "Pharmacological treatment"}]
|